58 research outputs found
Central benzodiazepine receptors in hippocampal sclerosis and idiopathic generalised epilepsies and opiod receptors in reading epilepsy
Background: Epilepsy is the most common serious disease of the brain. In order to better understand the processes and neuronal circuits involved in the pathophysiology of the epilepsies and to provide structural / functional correlations, positron emission tomography (PET) needs to be evaluated in the light of high quality MRI. Aims: To determine the extent and amount of central benzodiazepine/GABAA receptor (cBZR) abnormalities in mesial temporal lobe epilepsy (mTLE) due to hippocampal sclerosis (HS); to quantify cBZR in idiopathic generalised epilepsy (IGE) and the effect of treatment with sodium valproate (VPA); to investigate dynamic changes of opioid receptors in reading epilepsy (RE) at the time of reading-induced seizures. Methods: 11C-flumazenil (FMZ)-PET scans of 37 controls, 25 candidates for temporal lobe resections with HS, and 10 patients with IGE before and after taking VPA, were analysed with statistical parametric mapping (SPM) and a partial-volume-effect (PVE) corrected regions-of-interest approach to quantify FMZ binding to cBZR. Paired 11C-diprenorphine (DPN)-PET scans of 6 control subjects and 5 patients with RE were analysed with SPM to detect significant localised reductions of DPN binding during reading-induced seizures implying a focal release of endogenous opioids. Results: Using SPM, reductions of cBZR were restricted to the sclerotic hippocampus in unilateral mTLE. Using PVE correction loss of cBZR in HS was shown to be over and above that due to neurone loss and hippocampal atrophy. In-vivo 1IC-FMZ-PET correlated well with ex-vivo 3H-FMZ autoradiography in HS. Subtle reductions of cBZR are seen contralaterally in unilateral mTLE in 30%. cBZR in IGE are increased in the cortex and thalamus, and FMZ binding is not affected by VPA. Endogenous opioids are released locally in the left temporo-parietal cortex at the time of reading-induced seizures. Conclusions: The identification of functional abnormalities of major inhibitory neurotransmitter systems, over and above structural abnormalities, has profound implications for the presurgical investigation of patients, in whom MRI does not reveal a relevant underlying lesion. Elucidation of the neurochemical and functional abnormalities underlying seizures assists the design of new anti-epileptic drugs and helps to identify neurochemical abnormalities underlying specific epilepsy syndromes
ë°ìŽí° ë§ìŽëì êž°ë°í ì íŒì§ ëì ìŠìì ìíì êŽë šë ëê°ê° ëŽ ëí
íìë
ŒëŹž (ë°ìŹ)-- ììžëíê” ëíì ìêłŒëí ìíêłŒ, 2017. 8. ì ìČêž°.Introduction: We introduce a new data-mining method to select interictal pathologic activities based on the outcome of resective epilepsy surgery defined as the presence/absence of seizures in neocortical epilepsy (NE).
Methods: We analyzed electrocorticographies from 39 patients with medically intractable NE. We separately analyzed 37 frequency-bins from 0.9 to 600 Hz to select the bands related to the seizure outcome. An automatic detector using amplitude-duration-number thresholds was used. The two different interictal electrocorticography datasets containing epileptiform activities were selected. In the first training dataset, the automatic detector was optimized to best differentiate the seizure-free group from the not-seizure-free-group based on the ranks of resection percentages of the activities detected using a genetic algorithm. We optimized in a patient group with 20 patients and validated optimized threshold in a different patient group with 19 patients to evaluate stability of results in a different patient group. Significant reproducibility was determined from expected numbers of significant results from the binomial distribution. The differences in the resection percentage of the detected activities between the seizure outcome groups (Dif-R) in the validation dataset were measured.
Results: There were 16 seizure-free (41%) of 39 patients. The mean follow-up duration was 21 ± 11 months (13 to 44 months). In the validation dataset from the different 19 patient group, delta in 2.0 â 2.3 Hz were significantly reproducible. Low-frequency activities (LFAs) between 4.9 â 43 Hz including theta, alpha, beta and low-gamma were significantly reproducible. High-gamma in 62 and 75 Hz and high-frequency activities (HFAs) in 108 and 322 Hz were reproducibly related to seizure outcome. Dif-Rs in the different patient group was about mean 10 â 20 % in reproducible frequency-bins. In LFAs, the resection of detected activities were positively related with better seizure outcome as intended. However, high-gamma activities are paradoxically negatively related with seizure outcome.
Conclusion: Using the presented method, in a different interictal segment validation, we achieved Dif-Rs that were higher than the best manual and automatic HFA detections described in the literature using only training dataset (17 to 27 %). In a different patient group validation, our results, 10 â 20 % Dif-Rs were comparable to literature analyzing only training dataset. A new method selecting pathologic activities based on seizure outcome can be potentially useful finding pathologic activities to be resected.1 Introduction 1
2 Methods 11
3 Results 15
4 Discussion 17
5 Conclusion 21
References 22
Abstract (Korean) 30Docto
Refractory Epilepsy: Natural History and Pathogenesis
Despite antiepileptic drug (AED) treatment, up to one third of patients continue to have seizures. Refractory epilepsy is a poorly understood subject, both in terms of its development and pathogenesis. Outcome studies have focused on terminal remission, but little is known about the natural history of epilepsy in terms of its progression to eventual remission or persistent refractoriness. Such an understanding is essential to the formulation of a rational management approach. Natural history of treated epilepsy Long-term outcome of newly diagnosed patients was investigated longitudinally for up to 15 years. Response to the first drug and successive substitution monotherapy or polytherapy was analysed. Outcome among patients with different neuropathologies was compared in a separate study. Among 470 newly diagnosed patients, 64% became seizure-free for at least a year. Patients with high numbers of pre-treatment seizures were less likely to become seizure- free. Epilepsy was controlled by the first AED in 47% of patients. Patients with symptomatic or cryptogenic epilepsy were less likely to become seizure-free on the first AED, partly because they were more likely to develop intolerable side-effects compared to those with idiopathic epilepsy. The majority of such withdrawals occurred at low doses of the three most commonly prescribed AEDs, carbamazepine (CBZ), sodium valproate (VPA) and lamotrigine (LTG). Over 90% of seizure-free patients also required only a moderate daily dose (up to 800mg CBZ, ISOOmg VPA, 300mg LTG). The probability of attaining seizure-freedom declined progressively with successive AED regimens. While 47% became seizure-free on the first drug, only 10% did so on the second drug and 1% on the third monotherapy. Three percent became seizure-free on a combination of two AEDs. The subsequent seizure-free rate was 41% among those failing the first drug due to intolerable side effects, but only 11% among those in whom the first AED was well tolerated but did not control the seizures completely. Among patients with inadequate seizure control on the first well tolerated AED, those who received substituted monotherapy and those who received add-on treatment had similar seizure-free rates and incidence of intolerable side effects. More patients became seizure- free on combinations involving an AED that blocked sodium channels and one with multiple mechanisms of action than on other combinations. Combination treatment was more effective when prescribed immediately after the first drug failed due to inadequate seizure control than w'hen it was delayed until a substitution also proved unsuccessful. In a separate study, compared with other pathologies identified on magnetic resonance imaging, mesial temporal sclerosis (MTS) was associated with the worst prognosis, although 42% did become seizure-free on AED treatment. Pathogenesis of refractory epilepsy Two candidate biological mechanisms in the pathogenesis of refractory epilepsy were studied. Glutamic acid decarboxylase (GAD) autoantibody titres were compared between patients with controlled and uncontrolled epilepsy. GAD catalyses the conversion of glutamate to y-aminobutyric acid, the major inhibitory neurotransmitter. Autoantibodies against GAD are prevalent in insulin dependent diabetes mellitus, and have been documented in anecdotal cases of refractory epilepsy. The drug transporter P-glycoprotein (P-gp) was investigated in a series of laboratory-based pilot experiments. Encoded by the multidrug resistance gene family (MDRl in man and mdrla and lb in rodents), P-gp actively extrudes a wide range of xenobiotics out of cells. Its over-expression is thought to underlie the resistance of some cancers to multiple chemotherapeutics. P-gp is physiologically expressed at high level in the cerebral capillary endothelium where it contributes to the integrity of the blood-brain barrier. Overexpression of P-gp in brain tissues resected from patients with refractory epilepsy has been reported in surgical case series. Mdrla(-/-) mice devoid of cerebral P-gp were used to determine whether AEDs were substrates of the drug transporter. The pharmacokinetic profiles of four established and four new AEDs in mdrla(-/-) mice and wild-type mice were compared. The technique of quantitative reverse transcriptase-polymerase chain reaction was developed and validated to determine tissue concentration of mdrl mRNA as an indicator of gene expression. Expression was determined in different regions of the normal rat brain, and in brains of genetically epilepsy-prone rats (GEPRs) subject to a single audiogenic seizure. To explore the effect of tissue damage, a laser beam was impinged upon the cerebral cortex of rats. Mdrl expression was measured in tissues surrounding the focal necrosis. Human brain tissues resected during epilepsy surgery were also analysed for MDRl gene expression. There was no difference in GAD autoantibody titres between patients with controlled and uncontrolled epilepsy. (Abstract shortened by ProQuest.)
Dynamics of brain states and cortical excitability in paroxysmal neurological conditions
Epilepsy and migraine are neurological conditions that are characterised by periods of disruption of normal neuronal functioning. Aside from this paroxysmal feature, both conditions share genetic mutations and altered cortical excitability. People with epilepsy appear to be diagnosed with migraine more often than people without epilepsy and, likewise, people with migraine seem to be diagnosed with epilepsy more often than people without migraine. Changes in cortical excitability may help explain the pathophysiological link between both conditions, and could be a biomarker to monitor disease activity. In this thesis, the association between migraine and epilepsy and their relation to cortical excitability is further explored. A meta-analysis of previous population based studies provides epidemiological evidence for the co-occurrence of migraine and epilepsy. The combination of computer modelling with human electroencephalographic recordings offers insight into multi-stability of brain states in epilepsy. Results described in this thesis show that Transcranial Magnetic Stimulation can be used to measure cortical excitability, but that its use as a biomarker of disease activity in epilepsy is limited due to large interindividual variability. By combining Transcranial Magnetic Stimulation with electroencephalography, two novel variables that may contribute to cortical excitability are investigated: phase clustering, which possibly reflecting functional neuronal connectivity, and the non-linear residual of a stimulus-response curve, which may reflect brain state multi-stability. The results presented in this thesis suggest that the higher propensity to global synchronisation is not shared between epilepsy and migraine. These new variables have potential value to differentiate people with epilepsy, but not people with migraine, from normal controls
Prognosis of Patients with Epilepsy
BookWritten primarily for the physician who is responsible for the treatment of epileptic patients and the clinical investigator interested in the basic mechanisms underlying this disorder. The book also addresses itself to psychologists interested in the study of mind-brain relationships. Factors related to employability of the patient are discussed as well as characteristics of patients who have to be institutionalized
Towards Accurate Forecasting of Epileptic Seizures: Artificial Intelligence and Effective Connectivity Findings
LâĂ©pilepsie est une des maladies neurologiques les plus frĂ©quentes, touchant prĂšs dâun
pourcent de la population mondiale. De nos jours, bien quâenviron deux tiers des patients
Ă©pileptiques rĂ©pondent adĂ©quatement aux traitements pharmacologiques, il reste quâun tiers des
patients doivent vivre avec des crises invalidantes et imprévisibles. Quoique la chirurgie
dâĂ©pilepsie puisse ĂȘtre une autre option thĂ©rapeutique envisageable, le recours Ă la chirurgie de
résection demeure trÚs faible en partie pour des raisons diverses (taux de réussite modeste, peur
des complications, perceptions nĂ©gatives). Dâautres avenues de traitement sont donc souhaitables.
Une piste actuellement explorĂ©e par des groupes de chercheurs est de tenter de prĂ©dire les crises Ă
partir dâenregistrements de lâactivitĂ© cĂ©rĂ©brale des patients. La capacitĂ© de prĂ©dire la survenue de
crises permettrait notamment aux patients, aidants naturels ou personnels médical de prendre des
mesures de prĂ©caution pour Ă©viter les dĂ©sagrĂ©ments reliĂ©s aux crises voire mĂȘme instaurer un
traitement pour les faire avorter. Au cours des derniĂšres annĂ©es, dâimportants efforts ont Ă©tĂ©
dĂ©ployĂ©s pour dĂ©velopper des algorithmes de prĂ©diction de crises et dâen amĂ©liorer les
performances.
Toutefois, le manque dâenregistrements Ă©lectroencĂ©phalographiques intracrĂąniens (iEEG) de
longue durée de qualité, la quantité limitée de crises, ainsi que la courte durée des périodes
interictales constituaient des obstacles majeurs à une évaluation adéquate de la performance des
algorithmes de prĂ©diction de crises. RĂ©cemment, la disponibilitĂ© en ligne dâenregistrements iEEG
continus avec échantillonnage bilatéral (des deux hémisphÚres) acquis chez des chiens atteints
dâĂ©pilepsie focale Ă lâaide du dispositif de surveillance ambulatoire implantable NeuroVista a
partiellement facilitĂ© cette tĂąche. Cependant, une des limitations associĂ©es Ă lâutilisation de ces
donnĂ©es durant la conception dâun algorithme de prĂ©diction de crises Ă©tait lâabsence
dâinformation concernant la zone exacte de dĂ©but des crises (information non fournie par les
gestionnaires de cette base de données en ligne). Le premier objectif de cette thÚse était la mise
en oeuvre dâun algorithme prĂ©cis de prĂ©diction de crises basĂ© sur des enregistrements iEEG canins
de longue durée. Les principales contributions à cet égard incluent une localisation quantitative
de la zone dâapparition des crises (basĂ©e sur la fonction de transfert dirigĂ© âDTF), lâutilisation
dâune nouvelle fonction de coĂ»t via lâalgorithme gĂ©nĂ©tique proposĂ©, ainsi quâune Ă©valuation
quasi-prospective des performances de prĂ©diction (donnĂ©es de test dâun total de 893 jours). Les rĂ©sultats ont montrĂ© une amĂ©lioration des performances de prĂ©diction par rapport aux Ă©tudes
antérieures, atteignant une sensibilité moyenne de 84.82 % et un temps en avertissement de 10 %.
La DTF, utilisée précédemment comme mesure de connectivité pour déterminer le réseau
épileptique (objectif 1), a été préalablement validée pour quantifier les relations causales entre les
canaux lorsque les exigences de quasi-stationnarité sont satisfaites. Ceci est possible dans le cas
des enregistrements canins en raison du nombre relativement faible de canaux. Pour faire face
aux exigences de non-stationnarité, la fonction de transfert adaptatif pondérée par le spectre
(Spectrum weighted adaptive directed transfer function - swADTF) a Ă©tĂ© introduit en tant quâune
version variant dans le temps de la DTF. Le second objectif de cette thĂšse Ă©tait de valider la
possibilitĂ© dâidentifier les endroits Ă©metteurs (ou sources) et rĂ©cepteurs dâactivitĂ© Ă©pileptiques en
appliquant la swADTF sur des enregistrements iEEG de haute densité provenant de patients
admis pour Ă©valuation prĂ©-chirurgicale au CHUM. Les gĂ©nĂ©rateurs dâactivitĂ© Ă©pileptique Ă©taient
dans le volume réséqué pour les patients ayant des bons résultats post-chirurgicaux alors que
différents foyers ont été identifiés chez les patients ayant eu de mauvais résultats postchirurgicaux.
Ces rĂ©sultats dĂ©montrent la possibilitĂ© dâune identification prĂ©cise des sources et
rĂ©cepteurs dâactivitĂ©s Ă©pileptiques au moyen de la swADTF ouvrant la porte Ă la possibilitĂ© dâune
meilleure sĂ©lection dâĂ©lectrodes de maniĂšre quantitative dans un contexte de dĂ©veloppement
dâalgorithme de prĂ©diction de crises chez lâhumain.
Dans le but dâexplorer de nouvelles avenues pour la prĂ©diction de crises Ă©pileptiques, un
nouveau prĂ©curseur a aussi Ă©tĂ© Ă©tudiĂ© combinant lâanalyse des spectres dâordre supĂ©rieur et les
réseaux de neurones artificiels (objectif 3). Les résultats ont montré des différences
statistiquement significatives (p<0.05) entre lâĂ©tat prĂ©ictal et lâĂ©tat interictal en utilisant chacune
des caractéristiques extraites du bi-spectre. Utilisées comme entrées à un perceptron multicouche,
lâentropie bispectrale normalisĂ©e, lâentropie carrĂ© normalisĂ©e, et la moyenne ont atteint des
précisions respectives de 78.11 %, 72.64% et 73.26%.
Les résultats de cette thÚse confirment la faisabilité de prédiction de crises à partir
dâenregistrements dâĂ©lectroencĂ©phalographie intracrĂąniens. Cependant, des efforts
supplĂ©mentaires en termes de sĂ©lection dâĂ©lectrodes, dâextraction de caractĂ©ristiques, dâutilisation
des techniques dâapprentissage profond et dâimplĂ©mentation Hardware, sont nĂ©cessaires avant
lâintĂ©gration de ces approches dans les dispositifs implantables commerciaux.----------ABSTRACT
Epilepsy is a chronic condition characterized by recurrent âunpredictableâ seizures. While
the first line of treatment consists of long-term drug therapy about one-third of patients are said to
be pharmacoresistant. In addition, recourse to epilepsy surgery remains low in part due to
persisting negative attitudes towards resective surgery, fear of complications and only moderate
success rates. An important direction of research is to investigate the possibility of predicting
seizures which, if achieved, can lead to novel interventional avenues.
The paucity of intracranial electroencephalography (iEEG) recordings, the limited number of
ictal events, and the short duration of interictal periods have been important obstacles for an
adequate assessment of seizure forecasting. More recently, long-term continuous bilateral iEEG
recordings acquired from dogs with naturally occurring focal epilepsy, using the implantable
NeuroVista ambulatory monitoring device have been made available on line for the benefit of
researchers. Still, an important limitation of these recordings for seizure-prediction studies was
that the seizure onset zone was not disclosed/available. The first objective of this thesis was to
develop an accurate seizure forecasting algorithm based on these canine ambulatory iEEG
recordings. Main contributions include a quantitative, directed transfer function (DTF)-based,
localization of the seizure onset zone (electrode selection), a new fitness function for the
proposed genetic algorithm (feature selection), and a quasi-prospective assessment of seizure
forecasting on long-term continuous iEEG recordings (total of 893 testing days). Results showed
performance improvement compared to previous studies, achieving an average sensitivity of
84.82% and a time in warning of 10 %.
The DTF has been previously validated for quantifying causal relations when quasistationarity
requirements are met. Although such requirements can be fulfilled in the case of
canine recordings due to the relatively low number of channels (objective 1), the identification of
stationary segments would be more challenging in the case of high density iEEG recordings. To
cope with non-stationarity issues, the spectrum weighted adaptive directed transfer function
(swADTF) was recently introduced as a time-varying version of the DTF. The second objective
of this thesis was to validate the feasibility of identifying sources and sinks of seizure activity
based on the swADTF using high-density iEEG recordings of patients admitted for pre-surgical monitoring at the CHUM. Generators of seizure activity were within the resected volume for
patients with good post-surgical outcomes, whereas different or additional seizure foci were
identified in patients with poor post-surgical outcomes. Results confirmed the possibility of
accurate identification of seizure origin and propagation by means of swADTF paving the way
for its use in seizure prediction algorithms by allowing a more tailored electrode selection.
Finally, in an attempt to explore new avenues for seizure forecasting, we proposed a new
precursor of seizure activity by combining higher order spectral analysis and artificial neural
networks (objective 3). Results showed statistically significant differences (p<0.05) between
preictal and interictal states using all the bispectrum-extracted features. Normalized bispectral
entropy, normalized squared entropy and mean of magnitude, when employed as inputs to a
multi-layer perceptron classifier, achieved held-out test accuracies of 78.11%, 72.64%, and
73.26%, respectively.
Results of this thesis confirm the feasibility of seizure forecasting based on iEEG recordings;
the transition into the ictal state is not random and consists of a âbuild-upâ, leading to seizures.
However, additional efforts in terms of electrode selection, feature extraction, hardware and deep
learning implementation, are required before the translation of current approaches into
commercial devices
- âŠ